Administration, OralAntineoplastic Combined Chemotherapy ProtocolsBridged Bicyclo Compounds, Heterocyclic
Dr. Harold N. Keer, MD
NPI1124154398
- Publications
- 33
- Clinical trials
- 2
- Industry payments
- $70
- State license
- 1
- Year NPI issued
- 2007
- Practice address
- 300 Pasteur Dr, Stanford, CA 94305-2200
- Practice phone
- Call (650) 723-4000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Dr. Keer's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Harold N. Keer is a hematologist and oncologist in Stanford, California
Dr. Keer practices in Stanford, California.
Dr. Keer's NPI, 1124154398, was assigned on February 24, 2007. Dr. Keer graduated from Feinberg School of Medicine in 1990. Dr. Keer holds California license G78924.
NPI and contact details
- NPI
- 1124154398NPI Registry (opens in a new tab)
- NPI enumeration date
- February 24, 2007
- NPI status
- Active
- Practice phone
- (650) 723-4000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Medical school graduation
- 1990
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dr. Harold N. Keer's practice address is in Stanford, California
Dr. Keer's practice address in the NPI Registry is 300 Pasteur Dr, Stanford, CA 94305-2200. The practice phone is (650) 723-4000.
- NPI Registry address300 Pasteur Dr, Stanford, CA 94305-2200Phone(650) 723-4000
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dmand AI tracks the EHR system at Dr. Harold N. Keer's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Keer practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Dr. Keer's practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Keer practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Harold N. Keer is one of 1,502 hematologists and oncologists in California
Hematology and oncology is Dr. Keer's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Keer is licensed in California.
Specialties and state licenses
- Hematology and oncology, CaliforniaPrimary
Hematologists and oncologists near Dr. Keer
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Harold N. Keer has 33 publications on record
Dmand AI links 33 papers to Dr. Keer, published from 2010 to 2025. 2018 was the busiest year, with 4. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Azacitidine and Leukemia, Myeloid, Acute. Dr. Keer has published most often in Clin Cancer Res. Dr. Keer's most frequent co-authors are Gail J. Roboz, MD, Franklin D. Gaylis, MD and Jean-Pierre Issa, MD.
Papers33
Years published2010 to 2025
Dr. Keer's papers by year, 2012 to 2025
Topics Dr. Keer writes about most
- Antineoplastic Combined Chemotherapy Protocols
- Azacitidine
- Leukemia, Myeloid, Acute
- Ovarian Neoplasms
- Tumor Cells, Cultured
- Administration, Oral
- Antineoplastic Agents
- Decitabine
Dr. Keer's most frequent co-authors
- Gail J. Roboz, MD8 shared papers
- Franklin D. Gaylis, MD3 shared papers
- Jean-Pierre Issa, MD3 shared papers
Recent publications by Dr. Keer
Administration, IntravenousAdministration, OralAntineoplastic Combined Chemotherapy Protocols
fms-Like Tyrosine Kinase 3GenomicsLeukemia, Myeloid, Acute
See who Dr. Keer researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Keer works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Harold N. Keer has worked on 2 clinical trials
Dmand AI links Dr. Keer to 2 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic and Leukemia, Myeloid.
Conditions in Dr. Keer's trials
- Leukemia, Myeloid, Acute
- Leukemia, Myelomonocytic, Chronic
- Leukemia, Myeloid
- Myelodysplastic-Myeloproliferative Diseases
Recent clinical trials with Dr. Keer
A Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose) (opens in a new tab)
Enrolling by invitationPhase 2
Leukemia, Myelomonocytic, ChronicMyelodysplastic-Myeloproliferative DiseasesASTX727
Guadecitabine Extension Study (opens in a new tab)
TerminatedPhase 2
Leukemia, Myeloid, AcuteLeukemia, MyeloidGuadecitabine
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Harold N. Keer received $70 in industry payments in 2018
CMS Open Payments shows 1 general payment to Dr. Keer from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Clovis Oncology, Inc. paid the most, $70.
Companies that paid Dr. Keer the most, 2018 to 2018
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Harold N. Keer graduated from Feinberg School of Medicine
Dr. Keer graduated from Feinberg School of Medicine in 1990.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Harold N. Keer's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Harold N. Keer
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Harold N. Keer's NPI number?
Dr. Harold N. Keer's NPI number is 1124154398. It was assigned on February 24, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Harold N. Keer?
Dr. Harold N. Keer is a hematologist and oncologist in Stanford, California. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Harold N. Keer practice?
Dr. Keer practices at 300 Pasteur Dr, Stanford, CA 94305-2200.
What is Dr. Harold N. Keer's office phone number?
The practice phone on file for Dr. Keer is (650) 723-4000.
What is Dr. Harold N. Keer's medical license number?
Dr. Keer holds California license G78924.
Where did Dr. Harold N. Keer go to medical school?
Dr. Keer graduated from Feinberg School of Medicine in 1990.
Has Dr. Harold N. Keer received payments from drug or device companies?
CMS Open Payments shows $70 in general payments to Dr. Keer from 1 company from 2018 to 2018. The largest total came from Clovis Oncology, Inc.
How long has Dr. Harold N. Keer been practicing?
Dr. Keer graduated from medical school in 1990, 36 years ago.
Does Dr. Harold N. Keer do research?
Dmand AI links 33 publications to Dr. Keer, published from 2010 to 2025. Dr. Keer has worked on 2 clinical trials.
Who does Dr. Harold N. Keer publish with?
Dr. Keer's most frequent co-authors are Gail J. Roboz, MD (8 shared papers), Franklin D. Gaylis, MD (3 shared papers) and Jean-Pierre Issa, MD (3 shared papers).
Selling to hematology and oncology practices?
See hematologists and oncologists in California by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card